Kestra Medical Technologies (KMTS) Change in Cash (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Change in Cash data on file, last reported at $115.9 million in Q1 2026.

• Change in Cash for Q1 2026 came in at $115.9 million, up 613.59% year-over-year; the trailing twelve-month figure through Jan 2026 was $237.0 million (up 504.02% YoY), and the FY2025 annual result was $229.3 million, up 3503.26% from the prior year.
• Change in Cash improved to $115.9 million in Q1 2026 per KMTS's latest filing, from -$25.8 million in the prior quarter.
• Over five years, Change in Cash peaked at $183.2 million in Q2 2025 and troughed at -$36.4 million in Q3 2025.
• A 3-year average of $34.5 million and a median of -$14.7 million in 2024 frame the typical range for Change in Cash.
• On a YoY basis, Change in Cash climbed as much as 2766.9% in 2025 and fell as far as 139.67% in 2025.
• A 3-year view of Change in Cash shows it stood at -$23.1 million in 2024, then slipped by 11.88% to -$25.8 million in 2025, then jumped by 549.39% to $115.9 million in 2026.
• Business Quant data shows KMTS's Change in Cash at $115.9 million in Q1 2026, -$25.8 million in Q4 2025, and -$36.4 million in Q3 2025.